BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29080512)

  • 1. Neuroleptic malignant syndrome following quetiapine treatment in a patient with dementia with Lewy bodies.
    Kobayashi R; Matsumoto Y; Hayashi H; Suzuki A; Otani K
    Asian J Psychiatr; 2017 Dec; 30():173-174. PubMed ID: 29080512
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic Malignant Syndrome Caused by Quetiapine in an Elderly Man with Lewy Body Dementia.
    Shea YF; Chu LW
    J Am Geriatr Soc; 2016 Sep; 64(9):e55-6. PubMed ID: 27564641
    [No Abstract]   [Full Text] [Related]  

  • 3. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
    Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
    Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome.
    Majic T; Mell T; Heinz A; Rapp MA
    Int Psychogeriatr; 2010 Jun; 22(4):678-9. PubMed ID: 20199702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal Neuroleptic Malignant Syndrome Associated With Quetiapine.
    Schattner A; Kitroser E; Cohen JD
    Am J Ther; 2016; 23(5):e1209-10. PubMed ID: 26132604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine-Induced Neuroleptic Malignant Syndrome.
    Saraiva R; Côrte-Real B; Cordeiro C; Gonçalves MJ; Abreu M; Coentre R
    Prim Care Companion CNS Disord; 2023 Mar; 25(2):. PubMed ID: 36963375
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Neuroleptic malignant syndrome associated with quetiapine.
    Karagianis J; Phillips L; Hogan K; LeDrew K
    Can J Psychiatry; 2001 May; 46(4):370-1. PubMed ID: 11387795
    [No Abstract]   [Full Text] [Related]  

  • 9. Butyrophenone-induced neuroleptic malignant syndrome in Lewy body dementia: A cautionary tale.
    Seebaluck J; Colebatch JG; Chan BS
    Emerg Med Australas; 2023 Feb; 35(1):183-184. PubMed ID: 36316025
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic Malignant Syndrome Secondary to Quetiapine in Critical Care: A Case Report.
    Nestor C; O'Brien D; Dwyer R
    A A Pract; 2020 Sep; 14(11):e01318. PubMed ID: 32985851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No recurrence of a neuroleptic malignant syndrome under quetiapine.
    Brieger P; Reinelt Y
    Aust N Z J Psychiatry; 2003 Oct; 37(5):627. PubMed ID: 14511095
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible neuroleptic malignant syndrome with quetiapine.
    Stanley AK; Hunter J
    Br J Psychiatry; 2000 May; 176():497. PubMed ID: 10912237
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome associated with quetiapine after withdrawal of olanzapine and donepezil, with EEG differential diagnosis of Creutzfeldt-Jakob disease].
    López Pardo P; Jiménez Rojas C; Ortiz Pascual A; Socorro García A
    Rev Esp Geriatr Gerontol; 2016; 51(5):301-2. PubMed ID: 26923263
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of extended-release Quetiapine causing recurrent low-grade fevers.
    Puthran R; Lai D
    Psychiatry Res; 2021 Jan; 295():113583. PubMed ID: 33246590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.
    Ballard C; Grace J; McKeith I; Holmes C
    Lancet; 1998 Apr; 351(9108):1032-3. PubMed ID: 9546516
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine.
    Matsumoto R; Kitabayashi Y; Nakatomi Y; Tsuchida H; Fukui K
    Am J Psychiatry; 2005 Apr; 162(4):812. PubMed ID: 15800166
    [No Abstract]   [Full Text] [Related]  

  • 18. [A Case of Neuroleptic Malignant Syndrome Associated with Undiagnosed Dementia with Lewy Bodies].
    Oka M; Komasawa N; Nishihara I; Fukuda M; Minami T
    Masui; 2015 Nov; 64(11):1190-2. PubMed ID: 26689073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's in a name?
    Damodoran SS
    Aust N Z J Psychiatry; 2000 Aug; 34(4):698-9. PubMed ID: 10954408
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropsychiatric systemic lupus erythematosus associated with neuroleptic malignant syndrome.
    Verdoot P; Constant EL; Seghers A
    Br J Psychiatry; 2008 Dec; 193(6):507-8. PubMed ID: 19043159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.